6 completed, 2 terminated, 1 active not recruiting, 1 recruiting. 10 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Completed 6, Terminated 2, Active not recruiting 1, Recruiting 1 |
Follow Fenfluramine: new trials by email Literature Review of Fenfluramine trials Research Report on Fenfluramine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study of Fenfluramine Hydrochloride in Rett Syndrome fenfluramine hydrochloride, Placebo - Rett Syndrome | Phase 3 | Recruiting | UCB BIOSCIENCES, Inc. | 200 | 2026-07-14 | 2026-11-17 |
| A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Fenfluramine (Hydrochloride) in Infants 1 Year to Less Than 2 Years of Age With Dravet Syndrome fenfluramine - Dravet Syndrome | Phase 3 | Completed | UCB BIOSCIENCES, Inc. | 25 | 2024-05-21 | 2026-09-17 |
| Fenfluramine for Adult Dravet Patients Fenfluramine - Dravet Syndrome, Dravet Syndrome, Intractable | Phase 3 | Terminated | University Health Network, Toronto | 7 | 2023-01-11 | 2026-05-05 |
| A Phase 3 Study to Examine the Efficacy and Safety of ZX008 in Subjects With CDKL5 Deficiency Disorder. Fenfluramine, Placebo - CDKL5 Deficiency Disorder, Generalized Tonic Clonic Seizure | Phase 3 | Active not recruiting | Zogenix, Inc. | 87 | 2022-03-08 | 2026-04-29 |
| Treatment of Sunflower Syndrome With ZX008 (Fenfluramine Hydrochloride) in Children and Young Adults (Ages 4-25). Fenfluramine Hydrochloride - Photosensitive Epilepsy | Phase 3 | Completed | Elizabeth Anne Thiele | 20 | 2019-05-31 | 2024-11-06 |
| A Study to Investigate the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution in Children and Adults With Epileptic Encephalopathy Including Dravet Syndrome and Lennox-Gastaut Syndrome ZX008 (Fenfluramine Hydrochloride) - Dravet Syndrome, Lennox Gastaut Syndrome | Phase 3 | Completed | Zogenix, Inc. | 412 | 2019-04-22 | 2026-11-18 |
| A Study to Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome ZX008 (Fenfluramine Hydrochloride) - Dravet Syndrome | Phase 3 | Terminated | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 5 | 2017-07-12 | 2023-11-13 |
| A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome ZX008 (Fenfluramine Hydrochloride), Matching Placebo - Dravet Syndrome | Phase 3 | Completed | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 87 | 2017-01-27 | 2022-11-02 |
| An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome ZX008 (Fenfluramine Hydrochloride) - Dravet Syndrome | Phase 3 | Completed | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 375 | 2016-06-08 | 2025-07-14 |
| A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) in Children and Young Adults With Dravet Syndrome ZX008 (Fenfluramine Hydrochloride), Matching Placebo - Dravet Syndrome, Seizure Disorder | Phase 3 | Completed | Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | 262 | 2016-01-15 | 2023-09-28 |
Epilepsies, Myoclonic (7) · Epilepsy (5) · Seizures (5) · Brain Diseases (4) · CDKL5 deficiency disorder (1) · Epilepsy, Reflex (1) · Epilepsy, Tonic-Clonic (1) · Lennox Gastaut Syndrome (1) · Rett Syndrome (1) · Spasms, Infantile (1)
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. (4) · UCB BIOSCIENCES, Inc. (2) · Zogenix, Inc. (2) · Elizabeth Anne Thiele (1) · University Health Network, Toronto (1)
United States (9) · Germany (7) · United Kingdom (7) · Belgium (6) · Italy (6) · Spain (6) · Canada (5) · France (5) · Japan (4) · Netherlands (4) · Australia (3) · Denmark (3) · Georgia (2) · Israel (2) · Poland (2)
Elizabeth Thiele, M.D., Ph.D. (1)
PMID 34768178, PMID 33540241, PMID 31790543, PMID 31862249, PMID 34676542, PMID 36562419, PMID 37543865, PMID 40072476, PMID 42400405
2016 (1), 2023 (1)